Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer

References

• American Cancer Society, Cancer facts and figures2007 Accessed on Mar 1, 2009. Available from: http://www.cancer.org
   Google Scholar
• MasonJBNutritional chemoprevention of colon cancerSem on Gastrointest Dis200213143153
   PubMedGoogle Scholar
• World Cancer Research Fund and American Institute for Cancer ResearchFood, Nutrition, Physical Activity, and the Prevention of Cancer: A Global PerspectiveWashington DC2007280289
   Google Scholar
• KushiLHByersTDoyleCthe American Cancer Society 2006 Nutrition and Physical Activity Guidelines Advisory CommitteeAmerican Cancer Society guidelines on nutrition and physical activity for cancer prevention: Reducing the risk of cancer with healthy food choices and physical activityCA Cancer J Clin20065625428117005596
   PubMed Web of Science ®Google Scholar
• SzendeBTyihakEKiraly-VeghelyZDose-dependent effects of resveratrol on proliferation and apoptosis in endothelial and tumor cell culturesExp Mol Med200032889210926121
   PubMed Web of Science ®Google Scholar
• TessitoreLDavitASarottoICaderniGResveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21CIP expressionCarcinogenesis2000211619162210910967
   PubMed Web of Science ®Google Scholar
• SengottuvelanMViswanathanPNaliniNChemopreventive effect of trans-resveratrol – a phytoalexin against colonic aberrant crypt foci and cell proliferation in 1,2-dimethylhydrazine induced colon carcinogenesisCarcinogenesis2006271038104616338953
   PubMed Web of Science ®Google Scholar
• SengottuvelanMNaliniNDietary supplementation of resveratrol suppresses colonic tumor incidence in 1,2 dimethylhydrazine-treated rats by modulating biotransforming enzyemes and aberrant crypt foci developmentBr J Nutr20069614515316870003
   PubMed Web of Science ®Google Scholar
• SchneiderYDurantonBGosseFSchleifferRSeilerNRaulFResveratrol inhibits intestinal tumorigenesis and modulates host-defense-related gene expression in an animal model of human familial adenomatous polyposisNutr Cancer20013910210711588890
   PubMed Web of Science ®Google Scholar
• ZieglerCRainwaterLWhelanJMcEnteeMFDietary resveratrol does not affect intestinal tumorigenesis in ApcMin/+ miceJ Nutr200413451014704285
   PubMed Web of Science ®Google Scholar
• GignacEABourquinLDInfluence of resveratrol and sulindac on intestinal tumor numbers in Min miceFASEB J200115A630
   Web of Science ®Google Scholar
• SaleSTunstallRGRupareliaKCPotterGAStewardWPGescherAJComparison of the effects of the chemopreventive agent resveratrol and its synthetic analog trans 3,4,5,4-tetramethoxystilbene (DMU-212) on adenoma development in the ApcMin/+ mouse and cyclooxygenase-2 in human derived colon cancer cellsInt J Cancer200511519420115688382
   PubMed Web of Science ®Google Scholar
• FontecaveMLepoivreMElleingandEGerezCGuittetOResveratrol, a remarkable inhibitor of ribonucleotide reductaseFEBS Lett19984212772799468322
   PubMed Web of Science ®Google Scholar
• StivalaLASavioMCarafoliFSpecific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrolJ Biol Chem2001276225862259411316812
   PubMed Web of Science ®Google Scholar
• KhandujaKLBhardwajAKaushikGResveratrol inhibits N-nitrosodiethylamine-induced ornathine decarboxylase and cyclooxygenase in miceJ Nutr Sci Vitaminol (Tokyo)200450616515228220
   PubMed Web of Science ®Google Scholar
• Holmes-McNaryMBaldwinASJrChemopreventive properties of trans-resveratrol are associated with inhibition of activation of the I-k-B kinaseCancer Res2000603477348310910059
   PubMed Web of Science ®Google Scholar
• KunduJKShinYKKimSHSurhYJResveratrol inhibits phorbol ester-induced expression of COX-2 and activation of NF-kappaB in mouse skin by blocking IkappaB kinase activityCarcinogenesis2006271465147416474181
   PubMed Web of Science ®Google Scholar
• BauerJASinclairDATherapeutic potential of resveratrol: the in vivo evidenceNat Rev Drug Discov2006549350616732220
   PubMed Web of Science ®Google Scholar
• GescherAJStewardWPRelationship between mechanisms, bioavailability and preclinical chemopreventive efficacy of resveratrol: A conundrumCancer Epidemiol Biomarkers Prev20031295395714578128
   PubMed Web of Science ®Google Scholar
• BoocockDJFaustGEPatelKRPhase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agentCancer Epidemiol Biomarkers Prev2007161246125217548692
   PubMed Web of Science ®Google Scholar
• RobbinsDHItzkowitzSHThe molecular basis of colon cancerMed Clin NA20028614671495
   PubMed Web of Science ®Google Scholar
• PolakisPThe many ways of Wnt in cancerCurr Opin Genet Dev200717455117208432
   PubMed Web of Science ®Google Scholar
• ReyaTCleversHWnt signaling in stem cells and cancerNature200543484385015829953
   PubMed Web of Science ®Google Scholar
• JohalKSWooJSantosoCLow dose resveratrol inhibits Wnt signaling proximal to β-cateninProc Am Assoc Cancer Res200748350
   Google Scholar
• HopeCPlanutisKPlanoutieneMLow concentrations of resveratrol inhibit Wnt signal throughput in colon-derived cells: Implications for colon cancer preventionMol Nutr Food Res200852Suppl 1S52S6118504708
   PubMed Web of Science ®Google Scholar
• LiuGYuanXZengZAnalysis of gene expression and chemo-resistance of CD133+ cancer stem cells in glioblastomaMol Cancer200656717140455
   PubMed Web of Science ®Google Scholar
• MoyerMPStaufferJSManzanoLATanzerLRMerrimanRLNCM460, A normal human colon mucosal epithelial cell line in vitro cell dev biolAnimal199632315317
   Web of Science ®Google Scholar
• ChoYJHongJYChunHSLeeSKMinHYUltrasonication-assisted extraction of resveratrol from grapesJ Food Eng200677725730
   Web of Science ®Google Scholar
• HovanesKLiTWMunguiaJEBeta-catenin sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancerNat Genetics200128535711326276
   PubMed Web of Science ®Google Scholar
• van der FlierLGSabates-BellverJOvingIThe intestinal Wnt/TCF signatureGastroenterology200713262863217320548
   PubMed Web of Science ®Google Scholar
• LiTWTingJHYokoyamaNNBernsteinAvan de WeteringMWatermanMLWnt activation and alternative promoter repression of LEF1 in colon cancerMol Cell Biol2006265284529916809766
   PubMed Web of Science ®Google Scholar
• TestuOMcCormickFBeta-catenin regulates the expression of cyclin D1 in colon carcinoma cellsNature199939842242610201372
   PubMed Web of Science ®Google Scholar
• JhoEHZhangTDomonCJooCKFreundJNCostantiniFWnt/beta-catenin/tcf signaling induces the transcription of Axin 2, a negative regulator of the signaling pathwayMol Cell Biol2002221172118311809808
   PubMed Web of Science ®Google Scholar
• NikolovaTWuMBrumbarovKWnt conditioned media differentially affect the proliferation and differentiation of cord blood-derived CD133+ cells in vitroDifferentiation20077510011117316380
   PubMed Web of Science ®Google Scholar
• BarkerNvan EsJHKuipersJIdentification of stem cells in small intestine and colon by marker gene Lgr5Nature20074491003100817934449
   PubMed Web of Science ®Google Scholar
• LiuJLevensDMaking mycCurr Top Microbiol Immunol200630213216620023
   PubMed Web of Science ®Google Scholar
• NilssonJAClevelandJLMyc pathways provoking cell suicide and cancerOncogene2003229007902114663479
   PubMed Web of Science ®Google Scholar